The teratogenicity of the newer antiepileptic drugs - An update

Acta Neurologica Scandinavica

Volumn 130, Issue 4, 2014, Pages 234-238

  Vajda, F J E ^a   O'Brien, T J ^a   Lander, C M ^b   Graham, J ^a   Eadie, M J ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Lamotrigine; Levetiracetam; Malformation; Pregnancy; Teratogenesis; Topiramate

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; ETHOSUXIMIDE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; FRUCTOSE; PIRACETAM; TRIAZINE DERIVATIVE;

ANTICONVULSANT THERAPY; ARTICLE; EPILEPSY; FEMALE; FETUS MALFORMATION; FIRST TRIMESTER PREGNANCY; HUMAN; HYPOSPADIAS; MAJOR CLINICAL STUDY; MONOTHERAPY; PREGNANCY; SEIZURE; TERATOGENESIS; TERATOGENICITY; ABNORMALITIES, DRUG-INDUCED; ADULT; ANALOGS AND DERIVATIVES; DRUG EFFECTS; FETUS; REGISTER; RISK;

ABNORMALITIES, DRUG-INDUCED; ADULT; ANTICONVULSANTS; EPILEPSY; FEMALE; FETUS; FRUCTOSE; HUMANS; PIRACETAM; PREGNANCY; REGISTRIES; RISK; TRIAZINES; VALPROIC ACID;

EID: 84925349730     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/ane.12280     Document Type: Article

References (22)

1. Talati R, Scholle JUM, Phung OJ et al. Effectiveness and safety of antiepileptic medications in patients with epilepsy. Rockville (MO) Agency for Healthcare Research and Quality (US) 2011.
2. Vajda FJE, Lander CM, Hitchcock A et al. Changing Australian prescribing patterns for antiepileptic drugs in pregnancy and their possible consequences. J Clin Neurosci 2007;14:611-7.
3. Vajda FJE, Horgan D, Hollingworth S et al. The prescribing of antiepileptic drugs for pregnant Australian women. Report no. 11(12) EHCO82-EF Aust NZJ Obslet Gynaecol (2012);52:19-53.
4. Bobo WV, Davis RL, Toh S et al. Trends in the use of antiepileptic drugs among pregnant women in the US, 2001-2007: a medication exposure in pregnancy risk evaluation study. Paediatr Perinat Epidemiol 2012;26:578-88.
5. Man S-L, Petersen I, Thompson M, Nazareth I. Antiepileptic drugs during pregnancy in primary care: a UK population based study. PLoS One 2012;7:e52339.
6. Meadow SR. Congenital abnormalities and anticonvulsant drugs. Proc R Soc Med 1970;63:48-9.
7. Vajda FJE, Eadie MJ. Maternal valproate dosage and foetal malformations. Acta Neurol Scand 2005;112:137-43.
8. Tomson T, Battino D, Bonizzoni E et al. Dose-dependent risk of malformation with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011;10:609-17.
9. Tomson T, Battino D. Teratogenic effects of antiepileptic drugs. Lancet Neurol 2012;11:803-13.
10. Hernandez-Diaz S, Smith CR, Shen A et al. Comparative study of antiepileptic drugs during pregnancy. Neurology 2012;78:1692-9.
11. Holmes LB, Hernandez-Diaz S. Newer anticonvulsants: lamotrigine, topiramate and gabapentin. Birth Defects Res A Clin Mol Teratol 2012;94:599-606.
12. Molgaard-Nielsen D, Hviid A. Newer-generation antiepileptic drugs and the risk of major birth defects. J Am Med Assoc 2011;305:1996-2002.
13. Vajda FJE, Graham JE, Hitchcock AA, O'Brien TJ, Lander CM, Eadie MJ. Is lamotrigine a significant human teratogen? Observations from the Australian Pregnancy Register. Seizure 2010;19:558-61.
14. Mahwinney E, Craig J, Morrow J et al. Levetiracetam in pregnancy. Results from the UK and Ireland epilepsy and pregnancy registers. Neurology 2013;80:401-5.
15. Marguilis AV, Mirchell AA, Gilboa SM et al. Use of topiramate in pregnancy and risk of oral clefts. Am J Obstet Gynecol 2012;2012:207.
16. Vajda FJE, O'Brien TJ, Graham J, Lander CM, Eadie MJ. Associations between particular types of fetal malformation and antiepileptic drug exposure in utero. Acta Neurol Scand 2013;128:228-34.
17. Fujii H, Goel A, Bernard N et al. Pregnancy outcomes following gabapentin use. Results of a prospective comparative study. Neurology 2013;80:1565-70.
18. Vajda FJE, Graham J, Roten A, Lander CM, O'Brien TJ, Eadie MJ. Teratogenicity of the newer antiepileptic drugs - the Australian experience. J Clin Neurosci 2012;19:57-9.
19. Riley M, Halliday J. Birth defects in Victoria 1993-1998. Melbourne: Victorian Department of Human Services, 2000.
20. Morrow J, Russell A, Guthrie E et al. Malformation risk of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006;77:193-8.
21. Hunt S, Russell A, Smithson WH et al. Topiramate in pregnancy. Preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology 2008;71:272-6.
22. Green MW, Seeger JD, Peterson C, Bhattacharyya A. Utilization of topiramate during pregnancy and risk of birth defects. Headache 2012;52:1070-84.